Showing results (91-100 of 131) with videos related to
Sort By:
Pageof 14
Hepatology (Baltimore, Md.)|May 13, 2022
Nonalcoholic fatty liver disease risk and histologic severity are associated with genetic polymorphisms in childrenNidhi P Goyal, Sara B Rosenthal, Chanod Nasamran, et al.The Journal of Pediatrics|July 13, 2014
Medical status of 219 children with biliary atresia surviving long-term with their native livers: results from a North American multicenter consortiumVicky Lee Ng, Barbara H Haber, John C Magee, et al.Hepatology Communications|October 30, 2023
Sarcopenia is associated with osteopenia and impaired quality of life in children with genetic intrahepatic cholestatic liver diseaseJulia M Boster, Nathan P Goodrich, Cathie Spino, et al.Pediatric Radiology|July 27, 2023
Prospective study of quantitative liver MRI in cystic fibrosis: feasibility and comparison to PUSH cohort ultrasoundAlexander J Towbin, Wen Ye, Suiyuan Huang, et al.The Journal of Pediatrics|August 10, 2015
Baseline Ultrasound and Clinical Correlates in Children with Cystic FibrosisDaniel H Leung, Wen Ye, Jean P Molleston, et al.Hepatology Communications|May 4, 2022
Use of funded multicenter prospective longitudinal databases to inform clinical trials in rare diseases-Examination of cholestatic liver disease in Alagille syndromeBenjamin L Shneider, Binita M Kamath, John C Magee, et al.JAMA|April 28, 2011
Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trialJoel E Lavine, Jeffrey B Schwimmer, Mark L Van Natta, et al.Journal of Pediatric Gastroenterology and Nutrition|October 25, 2021
Neurodevelopmental Outcomes in Children With Inherited Liver Disease and Native LiverDaniel H Leung, Lisa G Sorensen, Wen Ye, et al.Hepatology (Baltimore, Md.)|March 10, 2022
Risk of variceal hemorrhage and pretransplant mortality in children with biliary atresiaLee M Bass, Wen Ye, Kieran Hawthorne, et al.Hepatology (Baltimore, Md.)|February 8, 2022
Randomized placebo-controlled trial of losartan for pediatric NAFLDMiriam B Vos, Mark L Van Natta, Niviann M Blondet, et al.Pageof 14